Mechanisms of cytosolic targeting of matrix metalloproteinase-2

Journal of Cellular Physiology

Volumn 227, Issue 10, 2012, Pages 3397-3404

  Ali, Mohammad A M ^a   Chow, Ava K ^a   Kandasamy, Arulmozhi D ^a   Fan, Xiaohu ^a   West, Lori J ^a   Crawford, Bryan D ^b   Simmen, Thomas ^c   Schulz, Richard ^a,c  

^a MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF NEW BRUNSWICK   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; TROPONIN I;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL HYPOXIA; CYTOSOL; ENDOPLASMIC RETICULUM; ENZYME LOCALIZATION; GOLGI COMPLEX; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REOXYGENATION; SECRETORY PATHWAY; SECRETORY VESICLE;

CELL HYPOXIA; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CYTOSOL; DNA, COMPLEMENTARY; ENDOPLASMIC RETICULUM; HEK293 CELLS; HELA CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MYOCYTES, CARDIAC; TRANSFECTION; TROPONIN I;

EID: 84862682540     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24040     Document Type: Article

References (34)

1. Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R. 2010. Titin is a target of matrix metalloproteinase-2: Implications in myocardial ischemia/reperfusion injury. Circulation 122: 2039-2047.
2. Anelli T, Alessio M, Mezghrani A, Simmen T, Talamo F, Bachi A, Sitia R. 2002. ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family. EMBO J 21: 835-844.
3. Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, Dahi S, Karliner JS, Lovett DH. 2007. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol 292: H1847-H1860.
4. Brunagel G, Shah U, Schoen RE, Getzenberg RH. 2003. Identification of calreticulin as a nuclear matrix protein associated with human colon cancer. J Cell Biochem 89: 238-243.
5. Butler GS, Overall CM. 2009. Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov 8: 935-948.
6. Cauwe B, Opdenakker G. 2010. Intracellular substrate cleavage: A novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit Rev Biochem Mol Biol 45: 351-423.
7. Chow AK, Cena J, El-Yazbi AF, Crawford BD, Holt A, Cho WJ, Daniel EE, Schulz R. 2007. Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart. J Mol Cell Cardiol 42: 896-901.
8. Coker ML, Doscher MA, Thomas CV, Galis ZS, Spinale FG. 1999. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am J Physiol 277: H777-H787.
9. Coppolino MG, Dedhar S. 1998. Calreticulin. Int J Biochem Cell Biol 30: 553-558.
10. Gilady SY, Bui M, Lynes EM, Benson MD, Watts R, Vance JE, Simmen T. 2010. Ero1alpha requires oxidizing and normoxic conditions to localize to the mitochondria-associated membrane (MAM). Cell Stress Chaperones 15: 619-629.
11. Hegde RS, Bernstein HD. 2006. The surprising complexity of signal sequences. Trends Biochem Sci 31: 563-571.
12. Hegde RS, Kang SW. 2008. The concept of translocational regulation. J Cell Biol 182: 225-232.
13. Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW. 2001. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 98: 8838-8843.
14. Kang SW, Rane NS, Kim SJ, Garrison JL, Taunton J, Hegde RS. 2006. Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway. Cell 127: 999-1013.
15. Karnabi E, Qu Y, Mancarella S, Yue Y, Wadgaonkar R, Boutjdir M. 2009. Silencing of Cav1.2 gene in neonatal cardiomyocytes by lentiviral delivered shRNA. Biochem Biophys Res Commun 384: 409-414.
16. Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R. 2004. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J 18: 690-692.
17. Levine CG, Mitra D, Sharma A, Smith CL, Hegde RS. 2005. The efficiency of protein compartmentalization into the secretory pathway. Mol Biol Cell 16: 279-291.
18. Ma J, Wollmann R, Lindquist S. 2002. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298: 1781-1785.
19. Massova I, Kotra LP, Fridman R, Mobashery S. 1998. Matrix metalloproteinases: Structures, evolution, and diversification. FASEB J 12: 1075-1095.
20. Matsumoto S, Katoh M, Saito S, Watanabe T, Masuho Y. 1997. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim Biophys Acta 1354: 159-170.
21. Miller JP, Holcomb J, Al-Ramahi I, de Haro M, Gafni J, Zhang N, Kim E, Sanhueza M, Torcassi C, Kwak S, Botas J, Hughes RE, Ellerby LM. 2010. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron 67: 199-212.
22. Rane NS, Yonkovich JL, Hegde RS. 2004. Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J 23: 4550-4559.
23. Sariahmetoglu M, Crawford BD, Leon H, Sawicka J, Li L, Ballermann BJ, Holmes C, Berthiaume LG, Holt A, Sawicki G, Schulz R. 2007. Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation. FASEB J 21: 2486-2495.
24. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R. 2005. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: A new intracellular target for matrix metalloproteinase-2. Circulation 112: 544-552.
25. Schulz R. 2007. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: Rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 47: 211-242.
26. Shaffer KL, Sharma A, Snapp EL, Hegde RS. 2005. Regulation of protein compartmentalization expands the diversity of protein function. Dev Cell 9: 545-554.
27. Simmen T, Lynes EM, Gesson K, Thomas G. 2010. Oxidative protein folding in the endoplasmic reticulum: Tight links to the mitochondria-associated membrane (MAM). Biochim Biophys Acta 1798: 1465-1473.
28. Si-Tayeb K, Monvoisin A, Mazzocco C, Lepreux S, Decossas M, Cubel G, Taras D, Blanc JF, Robinson DR, Rosenbaum J. 2006. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 169: 1390-1401.
29. Strongin AY. 2006. Mislocalization and unconventional functions of cellular MMPs in cancer. Cancer Metastasis Rev 25: 87-98.
30. Sung MM, Schulz CG, Wang W, Sawicki G, Bautista-Lopez NL, Schulz R. 2007. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol 43: 429-436.
31. Viappiani S, Nicolescu AC, Holt A, Sawicki G, Crawford BD, Leon H, van Mulligen T, Schulz R. 2009. Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol 77: 826-834.
32. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R. 2002. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106: 1543-1549.
33. Yoon GS, Lee H, Jung Y, Yu E, Moon HB, Song K, Lee I. 2000. Nuclear matrix of calreticulin in hepatocellular carcinoma. Cancer Res 60: 1117-1120.
34. Zenebe WJ, Nazarewicz RR, Parihar MS, Ghafourifar P. 2007. Hypoxia/reoxygenation of isolated rat heart mitochondria causes cytochrome c release and oxidative stress; evidence for involvement of mitochondrial nitric oxide synthase. J Mol Cell Cardiol 43: 411-419.